address1,city,zip,country,phone,website,industry,industryKey,industryDisp,sector,sectorKey,sectorDisp,longBusinessSummary,fullTimeEmployees,companyOfficers,compensationAsOfEpochDate,executiveTeam,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,payoutRatio,beta,forwardPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,tradeable,enterpriseValue,profitMargins,floatShares,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,impliedSharesOutstanding,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,forwardEps,enterpriseToEbitda,52WeekChange,SandP52WeekChange,quoteType,currentPrice,targetHighPrice,targetLowPrice,targetMeanPrice,targetMedianPrice,recommendationKey,numberOfAnalystOpinions,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,debtToEquity,returnOnAssets,returnOnEquity,freeCashflow,operatingCashflow,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,symbol,language,region,typeDisp,quoteSourceName,triggerable,customPriceAlertConfidence,regularMarketChangePercent,regularMarketPrice,shortName,longName,marketState,market,esgPopulated,hasPrePostMarketData,firstTradeDateMilliseconds,regularMarketChange,regularMarketDayRange,fullExchangeName,averageDailyVolume3Month,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekChangePercent,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,earningsCallTimestampStart,earningsCallTimestampEnd,isEarningsDateEstimate,epsTrailingTwelveMonths,epsForward,epsCurrentYear,priceEpsCurrentYear,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,sourceInterval,exchangeDataDelayedBy,cryptoTradeable,corporateActions,regularMarketTime,exchange,messageBoardId,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,trailingPegRatio
Hyllie Boulevard 34,Malmö,215 32,Sweden,46 7 35 17 91 18,https://www.ascelia.com,Biotechnology,biotechnology,Biotechnology,Healthcare,healthcare,Healthcare,"Ascelia Pharma AB (publ), a biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden. It develops Orviglance, a novel non-gadolinium diagnostic drug, which is in Phase 3 clinical trial for use in MRI-scans of the liver; and Oncoral, a novel oral irinotecan chemotherapy tablet, that is in Phase 2 clinical trial for the treatment of gastric cancer. The company has a collaboration agreement with the Taiho Oncology Inc. Ascelia Pharma AB (publ) was incorporated in 1999 and is headquartered in Malmö, Sweden.",11,"[{'maxAge': 1, 'name': 'Mr. Magnus O. Corfitzen', 'age': 49, 'title': 'Chief Executive Officer', 'yearBorn': 1975, 'fiscalYear': 2024, 'totalPay': 3871000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Andreas  Norlin', 'age': 54, 'title': 'Chief Scientific Officer', 'yearBorn': 1970, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Mikael  Widell', 'age': 66, 'title': 'Head of IR & Communications', 'yearBorn': 1958, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Julie Waras Brogren', 'age': 52, 'title': 'Deputy CEO & Chief Commercial Officer', 'yearBorn': 1972, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}]",1735603200,[],86400,4,4.38,4.4,4.29,4.65,4.38,4.4,4.29,4.65,0.0,1.053,-36.458336,1584137,1584137,978662,882516,882516,4.355,4.415,0,0,420944576,1.888589,9.44,4.1657,3.172975,0.0,0.0,SEK,False,389442816,0.0,87661195,96106000,0.24425,0.117910005,96215904,0.602,7.2674417,1735603200,1767139200,1743379200,-85067000,-1.22,-0.12,-5.462,-0.52903223,0.10500872,EQUITY,4.375,11.0,3.85,7.11667,6.5,none,3,57300000,0.596,-71304000,27240000,0.949,1.0,47.112,-0.41479,-1.4095501,-19170624,-64708000,0.0,0.0,0.0,SEK,ACE.ST,en-US,US,Equity,Delayed Quote,True,HIGH,-0.11415786,4.375,Ascelia Pharma AB,Ascelia Pharma AB (publ),PREPRE,se_market,False,False,1552464000000,-0.0050001144,4.29 - 4.65,Stockholm,978662,2.486411,1.3165443,1.888589 - 9.44,-5.0649996,-0.5365466,-52.90322,1747652340,1755082740,1755518400,1747641600,1747641600,False,-1.22,-0.12,0.22,19.886364,0.20930004,0.05024367,1.2020249,0.37883213,15,0,False,[],1751988598,STO,finmb_9237823,Europe/Stockholm,CEST,7200000,
